Selective serotonin reuptake inhibitors and serotonin and noradrenaline reuptake inhibitors improve cognitive function in partial responders depressed patients: Results from a prospective observational cohort study

Emotional Roles of Mono-Aminergic Neurotransmitters in Major Depressive Disorder and Anxiety Disorders

Liu, Y., Zhao, J., & Guo, W. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.02201 · Cited by 268 · see citing works

The anti-inflammatory mechanism of antidepressants – SSRIs, SNRIs

Gałecki, P., Mossakowska-Wójcik, J., & Talarowska, M. E. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.03.016 · Cited by 180 · see citing works

A standardization of the Novelty-Suppressed Feeding Test protocol in rats

Blasco‐Serra, A., González-Soler, E. M., Cervera‐Ferri, A., Teruel‐Martí, V., & Valverde‐Navarro, A. A. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.08.019 · Cited by 128 · see citing works

The microbiota–gut–brain axis and its modulation in the therapy of depression: Comparison of efficacy of conventional drugs and traditional Chinese medicine approaches

Bi, C., Guo, S., Hu, S., Chen, J., Ye, M., & Liu, Z. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106372 · Cited by 61 · see citing works

The antidepressant effects of apigenin are associated with the�promotion of autophagy via the mTOR/AMPK/ULK1 pathway

Zhang, X., Bu, H., Jiang, Y., Sun, G., Jiang, R., Huang, X., Duan, H., Huang, Z., & Wu, Q. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10491 · Cited by 49 · see citing works

New drugs in psychiatry: focus on new pharmacological targets

Caraci, F., Leggio, G. M., Salomone, S., & Drago, F. (2017) · F1000Research · doi:10.12688/f1000research.10233.1 · Cited by 34 · see citing works

The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis

Guerrera, C. S., Platania, G. A., Boccaccio, F. M., Sarti, P., Varrasi, S., Colliva, C., Grasso, M., Vivo, S. D., Cavallaro, D., Tascedda, F., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05300-y · Cited by 31 · see citing works

Predictors of functional outcome in patients with major depression and bipolar disorder: A dynamic network approach to identify distinct patterns of interacting symptoms

Platania, G. A., Guerrera, C. S., Sarti, P., Varrasi, S., Pirrone, C., Popović, D., Ventimiglia, A., Vivo, S. D., Cantarella, R. A., Tascedda, F., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0276822 · Cited by 23 · see citing works

Neurobiological and psychological factors to depression

Turner, M. (2024) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2024.2382091 · Cited by 22 · see citing works

Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study

Castellano, S., Torrent, C., Petralia, M. C., Godos, J., Cantarella, R. A., Ventimiglia, A., Vivo, S. D., Platania, S., Guarnera, M. A., Pirrone, C., et al. (2020) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s224754 · Cited by 16 · see citing works

Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease

Javaherian, K., Newman, B. M., Weng, H., Hassenstab, J. J., Xiong, C., Coble, D. W., Fagan, A. M., Benzinger, T. L. S., & Morris, J. C. (2018) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000284 · Cited by 16 · see citing works

Empirical evidence for the neurocognitive effect of nitrous oxide as an adjunctive therapy in patients with treatment resistant depression: A randomized controlled study.

Liu, J., Zhao, X.-T., Wei, X.-Y., Yan, D.-F., Ou, W.-W., Liao, M., Ji, S., Peng, Y.-B., Wu, S.-B., Wang, M., et al. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115326 · Cited by 8 · see citing works

High-tannin food enhances spatial memory and scatter-hoarding in rodents via the microbiota-gut-brain axis

Zhao, X., Guo, J., Wang, Y., & Yi, X. (2024) · Microbiome · doi:10.1186/s40168-024-01849-2 · Cited by 9 · see citing works

Depression in patients with ankylosing spondylitis

Ma, T., Geng, Y., & Li, P. (2022) · Rheumatology & autoimmunity · doi:10.1002/rai2.12020 · Cited by 7 · see citing works

Cognitive function in physically healthy, unmedicated individuals with major depression: Relationship with depressive symptoms and antidepressant response

Ou, A., Wu, G. W. Y., Kassel, M. T., Mackin, R. S., Rampersaud, R., Reus, V. I., Mellon, S. H., & Wolkowitz, O. M. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.02.115 · Cited by 6 · see citing works

Association of antidepressant and benzodiazepine use, and anticholinergic burden with cognitive performance in schizophrenia

Mäkipelto, V., Tuulio‐Henriksson, A., Hakulinen, C. A., Niemelä, S., Lähteenvuo, M., Wegelius, A., Kieseppä, T., Isometsä, E. T., Tiihonen, J., Kampman, O., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.02.025 · Cited by 5 · see citing works

Psychomotor retardation: What about the partial responders to magnetic transcranial stimulation in treatment resistant depression ?

Robin, A., Thomas-Ollivier, V., Sauvaget, A., Péré, M., & Bulteau, S. (2024) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2024.03.050 · Cited by 4 · see citing works

Platycodin D and voluntary running synergistically ameliorate memory deficits in 5 × FAD mice via mediating neuromodulation and neuroinflammation

Liu, J., Jiang, J., He, C., Zhou, L., Zhang, Y., Zhao, S., & Yang, Z. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1451766 · Cited by 6 · see citing works

New Psychometric Strategies for the Evaluation of Affective, Cognitive, and Psychosocial Functioning in Unipolar versus Bipolar Depression: Impact of Drug Treatment

Guerrera, C. S., Platania, G. A., Varrasi, S., Vivo, S. D., Pirrone, C., Vezzosi, V. F., Tascedda, F., Drago, F., Nuovo, S. D., Blom, J. M. C., et al. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007x04666230313091253 · Cited by 5 · see citing works

Therapeutic Effect of Novel Antidepressant Drugs Acting at Specific Receptors of Neurotransmitters and Neuropeptides

Werner, F.-M., & Coveñas, R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190410165243 · Cited by 5 · see citing works

Neurocognitive effects of theta burst stimulation for treatment-resistant depression in adults: A systematic review and recommendations for future research

Hutnyan, M., & McClintock, S. M. (2025) · Transcranial Magnetic Stimulation · doi:10.1016/j.transm.2025.100088 · Cited by 2 · see citing works

Increased Odds of Cognitive Impairment in Adults with Depressive Symptoms and Antidepressant Use

Meshkat, S., Wu, M., Tassone, V. K., Janssen‐Aguilar, R., Pang, H. Y. M., Jung, H. J., Lou, W. Y. W., & Bhat, V. (2024) · Pharmacopsychiatry · doi:10.1055/a-2381-2061 · Cited by 2 · see citing works

Alzheimer Disease—Link With Major Depressive Disorder and Efficacy of Antidepressants in Modifying its Trajectory

Fakih, N., & Fakhoury, M. (2024) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000779 · Cited by 1 · see citing works

Effects of SNRIs on emotion regulation and electrophysiological profiles in depressive patients: A correlational study with symptom remission

Ma, J., Yang, H., Li, R., Yuan, X., Pan, C., Li, F., Yang, D., Bie, Z., Zheng, J., & Li, Y. (2025) · Psychiatry Research · doi:10.1016/j.psychres.2025.116576 · Cited by 1 · see citing works

Association between Geriatric Nutritional Risk Index and Cognitive Function: National Health and Nutrition Examination SurveyPreprint

Wang, L., Wang, N., Li, W., Liu, H., Nie, L., Shi, M., Xu, W., Zuo, S., & Xu, X. (2024) · Research Square · doi:10.21203/rs.3.rs-5017881/v1

Attentional capacity and PTSD treatment response: prolonged exposure alone or combined with sertraline

PeConga, E. K., Gauthier, G. M., Mattson, E. K., Coyne, A. E., Feeny, N. C., & Zoellner, L. A. (2025) · Psychotherapy Research · doi:10.1080/10503307.2025.2592964

Does the brain behave differently during talking therapies? A narrative integrative review of neural responses in depression

Turner, M. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.12.026

Additional file 1 of The dynamic interaction between symptoms and pharmacological treatment in patients with major depressive disorder: the role of network intervention analysis

Guerrera, C. S., Platania, G. A., Boccaccio, F. M., Sarti, P., Varrasi, S., Colliva, C., Grasso, M., Vivo, S. D., Cavallaro, D., Tascedda, F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.24655773

Male sexual dysfunction in depressed men treated with fluoxetine versus escitalopram

Khaled, H. N., Elsayed, H. R., & Ahmed, S. A. S. (2026) · Egyptian Journal of Dermatology and Venerology · doi:10.4103/ejdv.ejdv_99_24

Advances in the Treatment of Cognitive Impairment in Major Depressive Disorder: Innovations and Research Challenges

Thakur, A., Jain, P., Sharma, M. K., Chauhan, N. S., Khatoon, N., Sahu, D., Ajazuddin, & Tamrakar, S. (2026) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-026-00331-7

Systematic review and meta-analysis on the efficacy and safety of combining repetitive transcranial magnetic stimulation with sertraline for adolescent depression in China

Sun, H., Zhang, L., Hu, J., Li, J., & Zheng, Z. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1893010

Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder

Herrera-Guzmán, I., Herrera-Abarca, J. E., Gudayol-Ferré, E., Herrera-Guzmán, D., Gómez-Carbajal, L., Peña-Olvira, M., Villuendas-González, E., & Joan, G.-O. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.03.006 · Cited by 120 · see citing works

The effect of selective serotonin reuptake inhibitors on cognitive impairment in patients with depression: A prospective, multicenter, observational study

Liu, L., Lv, X., Zhou, S., Liu, Q., Wang, J., Tian, H., Zhang, K., Wei, J., Wang, C., Chen, Q., et al. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.06.020 · Cited by 31 · see citing works

Major Depressive Disorder in recovery and neuropsychological functioning: Effects of selective serotonin reuptake inhibitor and dual inhibitor depression treatments on residual cognitive deficits in patients with Major Depressive Disorder in recovery

Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Abarca, J. E., Herrera-Guzmán, D., Montelongo-Pedraza, P., Padrós Blázquez, F., Peró-Cebollero, M., & Guàrdia-Olmos, J. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.10.009 · Cited by 94 · see citing works

P.2.c.036 Treatment compliance and health care costs of medicaid depressed adult patients treated with escitalopram versus citalopram

Erder, M. H., Wu, E. Q., Lü, M., Ben-Hamadi, R., & Beaulieu, N. (2008) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(08)70481-4

Effects of selective serotonin reuptake and dual serotonergic–noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder

Herrera-Guzmán, I., Gudayol-Ferré, E., Herrera-Guzmán, D., Guàrdia-Olmos, J., Hinojosa-Calvo, E., & Herrera-Abarca, J. E. (2009) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.10.015 · Cited by 160 · see citing works